Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Control Release ; 158(1): 148-55, 2012 Feb 28.
Article in English | MEDLINE | ID: mdl-22062689

ABSTRACT

Nanoparticles for cancer therapy and imaging are designed to accumulate in the diseased tissue by exploiting the Enhanced Permeability and Retention (EPR) effect. This limits their size to about 100nm. Here, using intravital microscopy and elemental analysis, we compare the in vivo localization of particles with different geometries and demonstrate that plateloid particles preferentially accumulate within the tumor vasculature at unprecedented levels, independent of the EPR effect. In melanoma-bearing mice, 1000×400nm plateloid particles adhered to the tumor vasculature at about 5% and 10% of the injected dose per gram organ (ID/g) for untargeted and RGD-targeted particles respectively, and exhibited the highest tumor-to-liver accumulation ratios (0.22 and 0.35). Smaller and larger plateloid particles, as well as cylindroid particles, were more extensively sequestered by the liver, spleen, and lungs. Plateloid particles appeared well-suited for taking advantage of hydrodynamic forces and interfacial interactions required for efficient tumoritropic accumulation, even without using specific targeting ligands.


Subject(s)
Drug Carriers/administration & dosage , Melanoma, Experimental/metabolism , Nanoparticles/administration & dosage , Silicon/administration & dosage , Animals , Drug Carriers/chemistry , Drug Carriers/pharmacokinetics , Green Fluorescent Proteins/genetics , Mice , Mice, Inbred C57BL , Mice, Transgenic , Microscopy, Electron, Scanning , Nanoparticles/chemistry , Nanoparticles/ultrastructure , Particle Size , Receptor Protein-Tyrosine Kinases/genetics , Receptor, TIE-2 , Silicon/chemistry , Silicon/pharmacokinetics , Surface Properties , Tissue Distribution
2.
Small ; 6(12): 1329-40, 2010 Jun 21.
Article in English | MEDLINE | ID: mdl-20517877

ABSTRACT

The realization that blood-borne delivery systems must overcome a multiplicity of biological barriers has led to the fabrication of a multistage delivery system (MDS) designed to temporally release successive stages of particles or agents to conquer sequential barriers, with the goal of enhancing delivery of therapeutic and diagnostic agents to the target site. In its simplest form, the MDS comprises stage-one porous silicon microparticles that function as carriers of second-stage nanoparticles. Cellular uptake of nontargeted discoidal silicon microparticles by macrophages is confirmed by electron and atomic force microscopy (AFM). Using superparamagnetic iron oxide nanoparticles (SPIONs) as a model of secondary nanoparticles, successful loading of the porous matrix of silicon microparticles is achieved, and retention of the nanoparticles is enhanced by aminosilylation of the loaded microparticles with 3-aminopropyltriethoxysilane. The impact of silane concentration and reaction time on the nature of the silane polymer on porous silicon is investigated by AFM and X-ray photoelectron microscopy. Tissue samples from mice intravenously administered the MDS support co-localization of silicon microparticles and SPIONs across various tissues with enhanced SPION release in spleen, compared to liver and lungs, and enhanced retention of SPIONs following silane capping of the MDS. Phantom models of the SPION-loaded MDS display negative contrast in magnetic resonance images. In addition to forming a cap over the silicon pores, the silane polymer provides free amines for antibody conjugation to the microparticles, with both VEGFR-2- and PECAM-specific antibodies leading to enhanced endothelial association. This study demonstrates the assembly and cellular association of a multiparticle delivery system that is biomolecularly targeted and has potential for applications in biological imaging.


Subject(s)
Drug Delivery Systems , Nanoparticles/chemistry , Animals , Cell Line , Mice , Microscopy, Atomic Force , Nanotechnology , Photoelectron Spectroscopy , Porosity
3.
Cancer Res ; 70(9): 3687-96, 2010 May 01.
Article in English | MEDLINE | ID: mdl-20430760

ABSTRACT

RNA interference (RNAi) is a powerful approach for silencing genes associated with a variety of pathologic conditions; however, in vivo RNAi delivery has remained a major challenge due to lack of safe, efficient, and sustained systemic delivery. Here, we report on a novel approach to overcome these limitations using a multistage vector composed of mesoporous silicon particles (stage 1 microparticles, S1MP) loaded with neutral nanoliposomes (dioleoyl phosphatidylcholine, DOPC) containing small interfering RNA (siRNA) targeted against the EphA2 oncoprotein, which is overexpressed in most cancers, including ovarian. Our delivery methods resulted in sustained EphA2 gene silencing for at least 3 weeks in two independent orthotopic mouse models of ovarian cancer following a single i.v. administration of S1MP loaded with EphA2-siRNA-DOPC. Furthermore, a single administration of S1MP loaded with-EphA2-siRNA-DOPC substantially reduced tumor burden, angiogenesis, and cell proliferation compared with a noncoding control siRNA alone (SKOV3ip1, 54%; HeyA8, 57%), with no significant changes in serum chemistries or in proinflammatory cytokines. In summary, we have provided the first in vivo therapeutic validation of a novel, multistage siRNA delivery system for sustained gene silencing with broad applicability to pathologies beyond ovarian neoplasms.


Subject(s)
Nanoparticles/administration & dosage , RNA, Small Interfering/administration & dosage , Silicon/administration & dosage , Animals , Cell Line, Tumor , Female , Gene Silencing , Genetic Therapy/methods , Humans , Liposomes/administration & dosage , Liposomes/chemistry , Liposomes/pharmacokinetics , Mice , Mice, Nude , Nanoparticles/chemistry , Ovarian Neoplasms/genetics , Ovarian Neoplasms/therapy , Phosphatidylcholines/administration & dosage , Phosphatidylcholines/chemistry , RNA, Small Interfering/genetics , RNA, Small Interfering/pharmacokinetics , Receptor, EphA2/genetics , Silicon/chemistry , Silicon/pharmacokinetics , Xenograft Model Antitumor Assays
4.
Chemphyschem ; 11(5): 1029-35, 2010 Apr 06.
Article in English | MEDLINE | ID: mdl-20162656

ABSTRACT

The use of mesoporous silicon particles for drug delivery has been widely explored thanks to their biodegradability and biocompatibility. The ability to tailor the physicochemical properties of porous silicon at the micro- and nanoscale confers versatility to this material. A method for the fabrication of highly reproducible, monodisperse, mesoporous silicon particles with controlled physical characteristics through electrochemical etching of patterned silicon trenches is presented. The particle size is tailored in the micrometer range and pore size in the nanometer range, the shape from tubular to discoidal to hemispherical, and the porosity from 46 to over 80%. In addition, the properties of the porous matrix are correlated with the loading of model nanoparticles (quantum dots) and their three-dimensional arrangement within the matrix is observed by transmission electron microscopy tomography. The methods developed in this study provide effective means to fabricate mesoporous silicon particles according to the principles of rational design for therapeutic vectors and to characterize the distribution of nanoparticles within the porous matrix.


Subject(s)
Cadmium Compounds/chemistry , Quantum Dots , Selenium Compounds/chemistry , Silicon/chemistry , Particle Size , Porosity
5.
Biomed Microdevices ; 9(5): 681-94, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17508286

ABSTRACT

A method for assembling Drosophila embryos in a microfluidic device was developed for studies of thermal perturbation of early embryonic development. Environmental perturbation is a complimentary method to injection of membrane-impermeable macromolecules for assaying genetic function and investigating robustness in complex biochemical networks. The development of a high throughput method for perturbing embryos would facilitate the isolation and mapping of signaling pathways. We immobilize Drosophila embryos inside a microfluidic device on minimal potential-energy wells created through surface modification, and thermally perturb these embryos using binary laminar flows of warm and cold solutions. We self-assemble embryos onto oil adhesive pads with an alcohol surfactant carrier fluid (detachment: 0.1 mL/min), and when the surfactant is removed, the embryo-oil adhesion increases to approximately 25 mL/min flow rates, which allows for high velocities required for sharp gradients of thermal binary flows. The microfluidic thermal profile was numerically characterized by simulation and experimentally characterized by fluorescence thermometry. The effects of thermal perturbation were observed to induce abnormal morphogenetic movements in live embryos by using time-lapse differential interference contrast (DIC) microscopy.


Subject(s)
Drosophila/embryology , Microfluidic Analytical Techniques/methods , Morphogenesis , Animals , Calibration , Computer Simulation , Dimethylpolysiloxanes/chemistry , Drosophila/cytology , Embryo, Nonmammalian , Equipment Design , Ethanol/chemistry , Methanol/chemistry , Microfluidic Analytical Techniques/instrumentation , Oils/chemistry , Polymers/chemistry , Surface Tension , Temperature , Water/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...